Here's Why Globus Medical (GMED) is a Strong Value Stock

Company Overview - Globus Medical, Inc. is a medical device company focused on developing and commercializing healthcare solutions for patients with musculoskeletal disorders, with sales operations in 51 countries worldwide [26]. Investment Insights - GMED is currently rated as a 2 (Buy) on the Zacks Rank, with a VGM Score of B, indicating it should be on investors' short lists [10][11]. - The company has seen three analysts revise their earnings estimates higher for fiscal 2024, with the Zacks Consensus Estimate increasing by $0.03 to $2.82 per share, and an average earnings surprise of 10.8% [19]. Style Scores - The Zacks Style Scores categorize stocks into Value, Growth, and Momentum, providing a comprehensive assessment of their potential to outperform the market [12][16]. - GMED has a Value Style Score of B, supported by a forward P/E ratio of 24.25, making it attractive for value investors [13][6]. - The VGM Score combines all Style Scores, helping to identify companies with the best value, growth forecasts, and momentum [16]. Performance Metrics - Stocks rated 1 (Strong Buy) have produced an average annual return of +25.41% since 1988, significantly outperforming the S&P 500 [8]. - To maximize investment success, it is recommended to focus on stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B [20].